findmyKOL

Rui Chen, MD

Basic profile

Michael E. DeBakey VA Medical Center

ORCID↗NPI↗
✓ Full record
RegionHouston, TX · South CentralSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding2005–2026Why? →

Rui Chen is an Endocrinology/Metabolic physician affiliated with Michael E. DeBakey VA Medical Center. OpenAlex indexes 48 publications with 1,673 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
48publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,673citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
18NIH grants · 2005–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2002 Holcombe Blvd
Houston, TX 77030

Telephone

713-791-1414

Provider last certified this registry record 6 Nov 2020.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    55.9%
    Insulin Analog20.6%
    Lantus Solostar100%
    Part D<11 patients
    Biguanide (metformin)19.1%
    Metformin Hcl100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    26.5%
    Statin26.5%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Hormonal (systemic)

    17.6%
    l-Thyroxine17.6%
    Levothyroxine Sodium100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

18 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”